imatinib siegfried 100mg film-coated tablets
kohne pharma gmbh - imatinib 100 mg - film-coated tablet
imatinib siegfried 400mg film-coated tablets
kohne pharma gmbh - imatinib 400 mg - film-coated tablet
reprapog 62.5mg/25mg film-coated tablets
1 a pharma gmbh - atovaquone 62.5 mg, proguanil hydrochloride 25 mg - film-coated tablet
reprapog 250mg/100mg film-coated tablets
1 a pharma gmbh - atovaquone 250 mg, proguanil hydrochloride 100 mg - film-coated tablet
imatinib teva pharma 400 milligram film coated tablet
teva pharma b.v. - imatinib mesilate - film coated tablet - 400 milligram - protein kinase inhibitors
imatinib teva pharma 100 milligram film coated tablet
teva pharma b.v. - imatinib mesilate - film coated tablet - 100 milligram - protein kinase inhibitors
imatinib teva pharma 100 mg film-coated tablets
teva pharma b.v. (utrecht) swensweg 5, 2031 ga haarlem, netherlands - imatinib - film-coated tablet - imatinib 100 mg - antineoplastic agents
imatinib teva pharma 400 mg film-coated tablets
teva pharma b.v. (utrecht) swensweg 5, 2031 ga haarlem, netherlands - imatinib - film-coated tablet - imatinib 400 mg - antineoplastic agents
binosto 70mg effervescent tablets
internis pharmaceuticals ltd - alendronic acid - effervescent tablet - 70mg - drugs affecting bone structure and mineralisation, bisphosphonates - treatment of postmenopausal osteoporosis. binosto 70 mg reduces the risk of vertebral and hip fractures.
blooms the chemist atorvastatin atorvastatin (as calcium trihydrate) 80 mg tablets blister pack
arrotex pharmaceuticals pty ltd - atorvastatin calcium trihydrate, quantity: 86.76 mg (equivalent: atorvastatin, qty 80 mg) - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; calcium carbonate; hyprolose; microcrystalline cellulose; polysorbate 80; croscarmellose sodium; titanium dioxide; macrogol 8000; hypromellose; purified talc; purified water; sodium chloride; dimeticone 100; benzoic acid; sorbic acid; methylcellulose; polysorbate 65; glyceryl distearate; silicon dioxide; dimeticonol; peg-4 stearate - as an adjunct to diet for the treatment of patients with hypercholesterolaemia. prior to initiating therapy with atorvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy and alcoholism) should be identified and treated.,indicated in hypertensive patients with multiple risk factors for coronary heart disease (chd), which may include diabetes, history of stroke or other cerebrovascular disease, peripheral vascular disease or existing asymptomatic chd (see clinical trials, prevention of cardiovascular disease) to reduce the risk of non-fatal myocardial infarction and non-fatal stroke. these effects do not replace the need to independently control known causes of cardiovascular mortality and morbidity such as hypertension, diabetes and smoking.